ACLS
Axcelis Technologies, Inc.NASDAQTechnologyAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
24.29
PEG
—
P/B
2.84
P/S
3.48
EV/EBITDA
17.62
DCF Value
$67.42
FCF Yield
3.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
44.9%
Operating Margin
14.2%
Net Margin
14.3%
ROE
11.7%
ROA
8.8%
ROIC
8.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $238.3M | $34.3M | $1.10 |
| FY 2025 | $839.0M | $120.2M | $3.80 |
| Q3 2025 | $213.6M | $26.0M | $0.83 |
| Q2 2025 | $194.5M | $31.4M | $0.98 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Technology
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.65
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.